These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 25890320)

  • 1. Generation of CCR5-defective CD34 cells from ZFN-driven stop codon-integrated mesenchymal stem cell clones.
    Manotham K; Chattong S; Setpakdee A
    J Biomed Sci; 2015 Mar; 22(1):25. PubMed ID: 25890320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient ZFN-Mediated Stop Codon Integration into the CCR5 Locus in Hematopoietic Stem Cells: A Possible Source for Intrabone Marrow Cell Transplantation.
    Chattong S; Chaikomon K; Chaiya T; Tangkosakul T; Palavutitotai N; Anusornvongchai T; Manotham K
    AIDS Res Hum Retroviruses; 2018 Jul; 34(7):575-579. PubMed ID: 29575905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo.
    Holt N; Wang J; Kim K; Friedman G; Wang X; Taupin V; Crooks GM; Kohn DB; Gregory PD; Holmes MC; Cannon PM
    Nat Biotechnol; 2010 Aug; 28(8):839-47. PubMed ID: 20601939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic editing of the HIV-1 coreceptor CCR5 in adult hematopoietic stem and progenitor cells using zinc finger nucleases.
    Li L; Krymskaya L; Wang J; Henley J; Rao A; Cao LF; Tran CA; Torres-Coronado M; Gardner A; Gonzalez N; Kim K; Liu PQ; Hofer U; Lopez E; Gregory PD; Liu Q; Holmes MC; Cannon PM; Zaia JA; DiGiusto DL
    Mol Ther; 2013 Jun; 21(6):1259-69. PubMed ID: 23587921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of CD34+ cells from CCR5-disrupted human embryonic and induced pluripotent stem cells.
    Yao Y; Nashun B; Zhou T; Qin L; Qin L; Zhao S; Xu J; Esteban MA; Chen X
    Hum Gene Ther; 2012 Feb; 23(2):238-42. PubMed ID: 21981760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene editing using a zinc-finger nuclease mimicking the CCR5Δ32 mutation induces resistance to CCR5-using HIV-1.
    Badia R; Riveira-Muñoz E; Clotet B; Esté JA; Ballana E
    J Antimicrob Chemother; 2014 Jul; 69(7):1755-9. PubMed ID: 24651827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted gene addition to human mesenchymal stromal cells as a cell-based plasma-soluble protein delivery platform.
    Benabdallah BF; Allard E; Yao S; Friedman G; Gregory PD; Eliopoulos N; Fradette J; Spees JL; Haddad E; Holmes MC; Beauséjour CM
    Cytotherapy; 2010 May; 12(3):394-9. PubMed ID: 20331411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromatin structure of two genomic sites for targeted transgene integration in induced pluripotent stem cells and hematopoietic stem cells.
    van Rensburg R; Beyer I; Yao XY; Wang H; Denisenko O; Li ZY; Russell DW; Miller DG; Gregory P; Holmes M; Bomsztyk K; Lieber A
    Gene Ther; 2013 Feb; 20(2):201-14. PubMed ID: 22436965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted disruption of the CCR5 gene in human hematopoietic stem cells stimulated by peptide nucleic acids.
    Schleifman EB; Bindra R; Leif J; del Campo J; Rogers FA; Uchil P; Kutsch O; Shultz LD; Kumar P; Greiner DL; Glazer PM
    Chem Biol; 2011 Sep; 18(9):1189-98. PubMed ID: 21944757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of anti-CCR5 ribozyme-transduced CD34+ hematopoietic progenitor cells in vitro and in a SCID-hu mouse model in vivo.
    Bai J; Gorantla S; Banda N; Cagnon L; Rossi J; Akkina R
    Mol Ther; 2000 Mar; 1(3):244-54. PubMed ID: 10933940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CCR5 Targeted Cell Therapy for HIV and Prevention of Viral Escape.
    Hütter G; Bodor J; Ledger S; Boyd M; Millington M; Tsie M; Symonds G
    Viruses; 2015 Jul; 7(8):4186-203. PubMed ID: 26225991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient modification of CCR5 in primary human hematopoietic cells using a megaTAL nuclease and AAV donor template.
    Sather BD; Romano Ibarra GS; Sommer K; Curinga G; Hale M; Khan IF; Singh S; Song Y; Gwiazda K; Sahni J; Jarjour J; Astrakhan A; Wagner TA; Scharenberg AM; Rawlings DJ
    Sci Transl Med; 2015 Sep; 7(307):307ra156. PubMed ID: 26424571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positive results with autologous transplant of ZFN-modified CD4 T-cells: a step toward a practical, functional cure for HIV.
    AIDS Patient Care STDS; 2011 Nov; 25(11):693. PubMed ID: 22023317
    [No Abstract]   [Full Text] [Related]  

  • 14. CD34+ cells from dental pulp stem cells with a ZFN-mediated and homology-driven repair-mediated locus-specific knock-in of an artificial β-globin gene.
    Chattong S; Ruangwattanasuk O; Yindeedej W; Setpakdee A; Manotham K
    Gene Ther; 2017 Jul; 24(7):425-432. PubMed ID: 28530652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CCR5Δ32 mutation and HIV infection: basis for curative HIV therapy.
    Allers K; Schneider T
    Curr Opin Virol; 2015 Oct; 14():24-9. PubMed ID: 26143158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical development and qualification of ZFN-mediated CCR5 disruption in human hematopoietic stem/progenitor cells.
    DiGiusto DL; Cannon PM; Holmes MC; Li L; Rao A; Wang J; Lee G; Gregory PD; Kim KA; Hayward SB; Meyer K; Exline C; Lopez E; Henley J; Gonzalez N; Bedell V; Stan R; Zaia JA
    Mol Ther Methods Clin Dev; 2016; 3():16067. PubMed ID: 27900346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human immunodeficiency virus infection of human placental cord blood CD34+AC133+ stem cells and their progeny.
    Hariharan D; Li Y; Campbell DE; Douglas SD; Starr SE; Ho W
    AIDS Res Hum Retroviruses; 1999 Nov; 15(17):1545-52. PubMed ID: 10580405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CCR5 Δ32 homozygous cord blood allogeneic transplantation in a patient with HIV: a case report.
    Duarte RF; Salgado M; Sánchez-Ortega I; Arnan M; Canals C; Domingo-Domenech E; Fernández-de-Sevilla A; González-Barca E; Morón-López S; Nogues N; Patiño B; Puertas MC; Clotet B; Petz LD; Querol S; Martinez-Picado J
    Lancet HIV; 2015 Jun; 2(6):e236-42. PubMed ID: 26423196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterozygosity for a defective gene for CC chemokine receptor 5 is not the sole determinant for the immunologic and virologic phenotype of HIV-infected long-term nonprogressors.
    Cohen OJ; Vaccarezza M; Lam GK; Baird BF; Wildt K; Murphy PM; Zimmerman PA; Nutman TB; Fox CH; Hoover S; Adelsberger J; Baseler M; Arthos J; Davey RT; Dewar RL; Metcalf J; Schwartzentruber DJ; Orenstein JM; Buchbinder S; Saah AJ; Detels R; Phair J; Rinaldo C; Margolick JB; Pantaleo G; Fauci AS
    J Clin Invest; 1997 Sep; 100(6):1581-9. PubMed ID: 9294127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lentivector Knockdown of CCR5 in Hematopoietic Stem and Progenitor Cells Confers Functional and Persistent HIV-1 Resistance in Humanized Mice.
    Myburgh R; Ivic S; Pepper MS; Gers-Huber G; Li D; Audigé A; Rochat MA; Jaquet V; Regenass S; Manz MG; Salmon P; Krause KH; Speck RF
    J Virol; 2015 Jul; 89(13):6761-72. PubMed ID: 25903342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.